A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
Clinical trial NCT04285580 · COMPLETED
Trial details
- NCT number
- NCT04285580
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-11
- Primary completion
- 2022-05-14
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.